Off Patent
May 04, 2012 at 13:45 | Source: CNBC-TV18
Apr 02, 2012 at 09:46 | Source: Reuters
Feb 06, 2012 at 11:11 | Source: Tech2.com
Feb 01, 2012 at 16:01 | Source: Tech2.com
Nov 22, 2011 at 22:02 | Source: CNBC-TV18
Interact & exchange stock tips & market info »
Related News »
Apple's Tim Cook and Samsung's Gee-Sung Choi kick off two-day settlement talks today in an effort to reach a patent agreement. But if recent activity surrounding the cases is any indication, the duo will be hard pressed to find common ground. Cook, Choi ...
May 21, 2012 at 16:51 | Source: PC Magazine
In the last 20 years, Nokia (NOK) has spent more than $50 billion to build its current patent portfolio. The company's patent portfolio includes more than 10,000 unique patents, and many of these patents are crucial to building a mobile phone today.
May 21, 2012 at 15:40 | Source: Seekingalpha.com
A cheap off-patent drug that is commonly used for arthritis could be a wonder treatment for amoebic parasites that infect 50 million people each year, 70,000 of them fatally, a study on Sunday said. Researchers in California found that auranofin ...
May 20, 2012 at 17:21 | Source: YAHOO!
For four years Chris Viehbacher has been bracing himself for a nasty turn. Since being appointed Sanofi’s chief executive in 2008, he has been diversifying the French drugmaker to prepare for the moment it loses US patent protection on one of its most lu ...
May 6, 2012 at 15:36 | Source: Financial Times
A cheap, off-patent drug could be a wonder treatment for amoebic parasites that infect 50 million people each year. A cheap off-patent drug that is commonly used for arthritis could be a wonder treatment for amoebic parasites that infect 50 ...
May 21, 2012 at 20:47 | Source: New York Daily News
It's been nearly a year since telecomm giant Nortel sold off its patent portfolio, and its buyers have been quick to turn it into a business. When Apple, Microsoft and four other technology companies spent $4.5 billion on the patent collection ...
May 21, 2012 at 15:04 | Source: CNET News
Thus, as you know from our previous conversations and formal communications to WIPO on this topic, the most recent cancer drug on the WHO model list is an off-patent drug registered with the FDA in 1996. Does the USPTO appreciate or even care what it means ...
May 25, 2012 at 11:10 | Source: Huffington Post
Pfizer's ($PFE) emerging markets and off-patent drug business is getting a new chief. Olivier Brandicourt, who currently heads up Pfizer's primary care unit, will take over the job June 1. He'll replace David Simmons, who has led the established ...
May 22, 2012 at 23:52 | Source: FiercePharma
This morning kicks off with an 8-K filing from the company in which it said it learned yesterday that Japan‘s high court affirmed the country’s patent offices decision to “invalidate the broadest claims” in one of Universal’s patents.
May 17, 2012 at 16:42 | Source: Barron's Online
Last November the best-selling drug of all time, Lipitor (atorvastatin), another cardiology mainstay, went off patent, though it wasn’t until earlier this month that multiple generics became available. The FDA said that it had approved 300 mg ...
May 17, 2012 at 19:05 | Source: Forbes